MEVION S250 Product Usage: Proton Radiation Therapy System

FDA Device Recall #Z-0411-2017 — Class II — October 20, 2016

Recall Summary

Recall Number Z-0411-2017
Classification Class II — Moderate risk
Date Initiated October 20, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Mevion Medical Systems, Inc.
Location Littleton, MA
Product Type Devices
Quantity 6 units

Product Description

MEVION S250 Product Usage: Proton Radiation Therapy System

Reason for Recall

Software defect:2D projection of contours in Verity. The defect causes structures to appear off from their true position in the DRR and the radiograph with an error that increases with the distance of the structure from isocenter

Distribution Pattern

US Nationwide Distribution in the states of: FL, MO, NJ, OH, OK

Lot / Code Information

Serial Numbers: S250-0001 through S250-0006

Other Recalls from Mevion Medical Systems, Inc.

Recall # Classification Product Date
Z-0827-2022 Class II Mevion S250 and S250i Proton Therapy Systems ha... Feb 1, 2022
Z-0485-2021 Class II MEVION S250i, MEVION S250; Proton Radiation Tre... Oct 19, 2020
Z-2686-2020 Class II MEVION S250 Proton Radiation Treatment System; ... Jun 23, 2020
Z-2406-2020 Class II MEVION S250i, MEVION S250; Proton Radiation Tre... May 15, 2020
Z-0705-2019 Class II MEVION S250i Oct 1, 2018

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.